ACRV - Wall Street Estimates - Acrivon Therapeutics, Inc. Common Stock

Healthcare - Biotechnology - NASDAQ - US

$ 5.78

4.14 %

$ 180 M

Market Cap

-2.17

P/E

Price Target Average

299.85%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

30.10%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Acrivon Therapeutics, Inc. Common Stock

Wall Street analysts predict an average 1-year price target for ACRV of $23.1 , with forecasts ranging from a low of $17 to a high of $30 .

ACRV Lowest Price Target Wall Street Target

17 USD 194.12%

ACRV Average Price Target Wall Street Target

23.1 USD 299.85%

ACRV Highest Price Target Wall Street Target

30 USD 419.03%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free